Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension

Obstructive sleep apnea (OSA) and primary aldosteronism are common in subjects with resistant hypertension; it is unknown, however, if the two disorders are causally related. This study relates plasma aldosterone and renin levels to OSA severity in subjects with resistant hypertension, and in those...

Full description

Saved in:
Bibliographic Details
Published inChest Vol. 131; no. 2; p. 453
Main Authors Pratt-Ubunama, Monique N, Nishizaka, Mari K, Boedefeld, Robyn L, Cofield, Stacey S, Harding, Susan M, Calhoun, David A
Format Journal Article
LanguageEnglish
Published United States 01.02.2007
Subjects
Online AccessGet more information
ISSN0012-3692
DOI10.1378/chest.06-1442

Cover

Loading…
Abstract Obstructive sleep apnea (OSA) and primary aldosteronism are common in subjects with resistant hypertension; it is unknown, however, if the two disorders are causally related. This study relates plasma aldosterone and renin levels to OSA severity in subjects with resistant hypertension, and in those with equally severe OSA but without resistant hypertension serving as control subjects. Seventy-one consecutive subjects referred to the University of Alabama at Birmingham (UAB) for resistant hypertension (BP uncontrolled on three medications) and 29 control subjects referred to UAB Sleep Disorders Center for suspected OSA were prospectively evaluated by an early morning plasma aldosterone concentration (PAC) and renin level, and by overnight, attended polysomnography. OSA (apnea-hypopnea index [AHI] > or = 5/h) was present in 85% of subjects with resistant hypertension. In these subjects, PAC correlated with AHI (rho = 0.44, p = 0.0002) but not renin concentration. Median PAC was significantly lower in control subjects compared to subjects with resistant hypertension (5.5 ng/dL vs 11.0 ng/dL, p < 0.05) and not related to AHI. In male subjects compared to female subjects with resistant hypertension, OSA was more common (90% vs 77%) and more severe (median AHI, 20.8/h vs 10.8/h; p = 0.01), and median PAC was significantly higher (12.0 ng/dL vs 8.8 ng/dL, p = 0.006). OSA is extremely common in subjects with resistant hypertension. A significant correlation between PAC and OSA severity is observed in subjects with resistant hypertension but not in control subjects. While cause and effect cannot be inferred, the data suggest that aldosterone excess may contribute to OSA severity.
AbstractList Obstructive sleep apnea (OSA) and primary aldosteronism are common in subjects with resistant hypertension; it is unknown, however, if the two disorders are causally related. This study relates plasma aldosterone and renin levels to OSA severity in subjects with resistant hypertension, and in those with equally severe OSA but without resistant hypertension serving as control subjects. Seventy-one consecutive subjects referred to the University of Alabama at Birmingham (UAB) for resistant hypertension (BP uncontrolled on three medications) and 29 control subjects referred to UAB Sleep Disorders Center for suspected OSA were prospectively evaluated by an early morning plasma aldosterone concentration (PAC) and renin level, and by overnight, attended polysomnography. OSA (apnea-hypopnea index [AHI] > or = 5/h) was present in 85% of subjects with resistant hypertension. In these subjects, PAC correlated with AHI (rho = 0.44, p = 0.0002) but not renin concentration. Median PAC was significantly lower in control subjects compared to subjects with resistant hypertension (5.5 ng/dL vs 11.0 ng/dL, p < 0.05) and not related to AHI. In male subjects compared to female subjects with resistant hypertension, OSA was more common (90% vs 77%) and more severe (median AHI, 20.8/h vs 10.8/h; p = 0.01), and median PAC was significantly higher (12.0 ng/dL vs 8.8 ng/dL, p = 0.006). OSA is extremely common in subjects with resistant hypertension. A significant correlation between PAC and OSA severity is observed in subjects with resistant hypertension but not in control subjects. While cause and effect cannot be inferred, the data suggest that aldosterone excess may contribute to OSA severity.
Author Cofield, Stacey S
Harding, Susan M
Boedefeld, Robyn L
Nishizaka, Mari K
Pratt-Ubunama, Monique N
Calhoun, David A
Author_xml – sequence: 1
  givenname: Monique N
  surname: Pratt-Ubunama
  fullname: Pratt-Ubunama, Monique N
  organization: Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA
– sequence: 2
  givenname: Mari K
  surname: Nishizaka
  fullname: Nishizaka, Mari K
– sequence: 3
  givenname: Robyn L
  surname: Boedefeld
  fullname: Boedefeld, Robyn L
– sequence: 4
  givenname: Stacey S
  surname: Cofield
  fullname: Cofield, Stacey S
– sequence: 5
  givenname: Susan M
  surname: Harding
  fullname: Harding, Susan M
– sequence: 6
  givenname: David A
  surname: Calhoun
  fullname: Calhoun, David A
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17296647$$D View this record in MEDLINE/PubMed
BookMark eNo1j8tOwzAQRb0oog9YskX-gRSP4zjNElW8pEqwgHU1diaqq9SJMk5R_55IwOreu7hHOksxi10kIe5ArSEvNw_-QJzWymZgjJ6JhVKgs9xWei6WzEc1bajstZhDqStrTbkQ7UeLfEKJbd1xomECysByoBYT1TJ1kulMQ0gX2TWyc5yG0adwJsktUS-xj4QyRMmjO5JPLL9DOkx_DpwwJnm49DQkihy6eCOuGmyZbv9yJb6enz63r9nu_eVt-7jLvCmKlBUWcgA3da2c0YVTUDhUk5O3CKp2BQJs8o1qGldXrrSGau0aJDIeGvR6Je5_uf3oTlTv-yGccLjs_7X1D8eeXQE
CitedBy_id crossref_primary_10_1016_j_hfc_2011_11_001
crossref_primary_10_1016_S1261_694X_08_74610_8
crossref_primary_10_1371_journal_pone_0204390
crossref_primary_10_1155_2017_8295010
crossref_primary_10_1007_s11906_014_0476_2
crossref_primary_10_1007_s00392_010_0148_4
crossref_primary_10_1016_j_rmr_2019_07_011
crossref_primary_10_1177_0300060519868337
crossref_primary_10_1038_ajh_2009_220
crossref_primary_10_1016_j_jash_2009_01_001
crossref_primary_10_1007_s10557_010_6256_6
crossref_primary_10_1016_j_chroma_2008_05_034
crossref_primary_10_1016_j_cjca_2015_05_003
crossref_primary_10_1164_rccm_201505_0998OC
crossref_primary_10_26442_SG29588
crossref_primary_10_1210_er_2017_00054
crossref_primary_10_1007_s11695_023_07031_1
crossref_primary_10_3390_endocrines3010003
crossref_primary_10_1007_BF03401320
crossref_primary_10_1210_clinem_dgae415
crossref_primary_10_1378_chest_07_1170
crossref_primary_10_1007_s11906_009_0055_0
crossref_primary_10_1161_HYPERTENSIONAHA_120_16902
crossref_primary_10_1097_CRD_0b013e318223bd08
crossref_primary_10_38109_2075_082X_2022_3_41_47
crossref_primary_10_1177_0300060520954691
crossref_primary_10_1016_j_ejphar_2015_06_024
crossref_primary_10_1038_jhh_2014_94
crossref_primary_10_1097_MNH_0b013e32835623f5
crossref_primary_10_1111_j_1751_7176_2008_07309_x
crossref_primary_10_1007_s11892_010_0161_z
crossref_primary_10_1016_j_amjmed_2021_07_041
crossref_primary_10_1210_jc_2009_1912
crossref_primary_10_1183_09031936_00226711
crossref_primary_10_1007_s11560_007_0119_6
crossref_primary_10_12688_f1000research_21669_1
crossref_primary_10_1038_hr_2015_19
crossref_primary_10_18786_2072_0505_2019_47_023
crossref_primary_10_1093_ajh_hpac091
crossref_primary_10_1161_HYP_0000000000000084
crossref_primary_10_1080_14779072_2024_2401875
crossref_primary_10_1016_j_jicc_2015_05_016
crossref_primary_10_1038_s41440_024_01970_7
crossref_primary_10_1155_2013_193010
crossref_primary_10_3390_jcm10143099
crossref_primary_10_3238_arztebl_2011_0725
crossref_primary_10_23736_S0026_4806_23_08466_5
crossref_primary_10_1378_chest_09_2954
crossref_primary_10_1007_s11906_010_0112_8
crossref_primary_10_1007_s40292_016_0136_5
crossref_primary_10_1016_j_nephro_2010_11_007
crossref_primary_10_1097_CM9_0000000000003431
crossref_primary_10_1016_j_jacc_2008_08_036
crossref_primary_10_1007_s11906_010_0135_1
crossref_primary_10_1016_j_yjmcc_2025_03_008
crossref_primary_10_4103_nmj_NMJ_129_19
crossref_primary_10_1007_s11936_019_0790_8
crossref_primary_10_1111_jch_12639
crossref_primary_10_1093_ajh_hpac079
crossref_primary_10_1016_j_smrv_2021_101473
crossref_primary_10_1007_s11906_008_0042_x
crossref_primary_10_1016_j_ccl_2010_07_002
crossref_primary_10_1055_s_0038_1626082
crossref_primary_10_1146_annurev_med_042711_135929
crossref_primary_10_1371_journal_pone_0089656
crossref_primary_10_3109_10641963_2013_804546
crossref_primary_10_1371_journal_pone_0192671
crossref_primary_10_1183_13993003_01261_2017
crossref_primary_10_1097_MNH_0000000000000047
crossref_primary_10_1016_j_rmr_2013_12_003
crossref_primary_10_1007_s00108_008_2194_9
crossref_primary_10_1016_j_ddmod_2011_02_006
crossref_primary_10_2147_IBPC_S223334
crossref_primary_10_1038_srep45241
crossref_primary_10_1113_jphysiol_2012_245159
crossref_primary_10_1111_jch_14269
crossref_primary_10_1007_s11906_022_01181_w
crossref_primary_10_1097_HJH_0b013e3282a9be30
crossref_primary_10_1007_s11906_007_0095_2
crossref_primary_10_1177_1076029610389023
crossref_primary_10_1016_j_ccl_2014_09_003
crossref_primary_10_1016_j_jss_2018_10_040
crossref_primary_10_1016_j_pcad_2008_02_004
crossref_primary_10_1097_HJH_0b013e3283492219
crossref_primary_10_3390_ijms24032245
crossref_primary_10_1055_a_1133_7255
crossref_primary_10_3389_fmed_2023_1200952
crossref_primary_10_1097_HJH_0000000000000238
crossref_primary_10_1161_HYPERTENSIONAHA_116_07806
crossref_primary_10_1111_1471_0528_12885
crossref_primary_10_1007_s00108_008_2195_8
crossref_primary_10_1016_j_ijcard_2016_11_069
crossref_primary_10_1016_j_ccep_2012_06_009
crossref_primary_10_1016_j_cjca_2012_03_010
crossref_primary_10_1038_hr_2009_56
crossref_primary_10_1038_hr_2014_80
crossref_primary_10_1016_j_semnephrol_2014_08_006
crossref_primary_10_1007_s11886_009_0059_z
crossref_primary_10_3389_fendo_2022_976979
crossref_primary_10_4061_2011_947246
crossref_primary_10_1097_HJH_0000000000002520
crossref_primary_10_1111_resp_12840
crossref_primary_10_1161_CIRCULATIONAHA_118_036675
crossref_primary_10_1210_clinem_dgaa952
crossref_primary_10_1016_j_cjca_2015_04_022
crossref_primary_10_1053_j_ajkd_2020_04_017
crossref_primary_10_1161_CIRCULATIONAHA_111_029892
crossref_primary_10_3389_fcvm_2021_798364
crossref_primary_10_1007_s10741_011_9286_7
crossref_primary_10_1097_HJH_0000000000000108
crossref_primary_10_1111_j_1365_2869_2010_00839_x
crossref_primary_10_2217_fca_10_123
crossref_primary_10_1038_hr_2016_11
crossref_primary_10_1038_jhh_2009_96
crossref_primary_10_1111_jch_12170
crossref_primary_10_12677_ACM_2023_133641
crossref_primary_10_1038_jhh_2011_47
crossref_primary_10_1038_jhh_2017_28
crossref_primary_10_1038_nrcardio_2012_141
crossref_primary_10_1007_s11906_025_01323_w
crossref_primary_10_1378_chest_12_0802
crossref_primary_10_1097_HJH_0b013e32833b9c63
crossref_primary_10_1016_S2213_2600_12_70051_6
crossref_primary_10_1038_hr_2009_73
crossref_primary_10_1164_rccm_201502_0383OC
crossref_primary_10_4061_2011_598694
crossref_primary_10_4061_2011_236239
crossref_primary_10_1111_jch_13259
crossref_primary_10_1007_s40292_014_0056_1
crossref_primary_10_1111_jsr_13726
crossref_primary_10_1186_s12872_017_0542_1
crossref_primary_10_1210_jc_2008_2116
crossref_primary_10_1016_j_amjmed_2016_01_039
crossref_primary_10_1513_AnnalsATS_201602_126OC
crossref_primary_10_1093_ajh_hpad022
crossref_primary_10_1016_S0140_6736_08_61622_0
crossref_primary_10_4061_2011_837817
crossref_primary_10_3389_fmed_2025_1497703
crossref_primary_10_3390_jcm8111872
crossref_primary_10_18705_1607_419X_2012_18_6_514_521
crossref_primary_10_1007_s11906_018_0819_5
crossref_primary_10_1007_s11906_017_0728_z
crossref_primary_10_1007_s11906_012_0289_0
crossref_primary_10_1007_s11906_016_0641_x
crossref_primary_10_1097_HJH_0000000000003822
crossref_primary_10_7189_jogh_08_010405
crossref_primary_10_1097_HJH_0b013e32833f0e7e
crossref_primary_10_1164_rccm_202003_0586UP
crossref_primary_10_3109_03009734_2012_707253
crossref_primary_10_1002_alr_23079
crossref_primary_10_1007_s12020_024_03798_0
crossref_primary_10_1016_j_jash_2011_05_003
crossref_primary_10_3390_jcm9030836
crossref_primary_10_1253_circj_CJ_23_0489
crossref_primary_10_4061_2011_162804
crossref_primary_10_1161_HYPERTENSIONAHA_119_13935
crossref_primary_10_1155_2015_408574
crossref_primary_10_4061_2011_340929
crossref_primary_10_1164_rccm_201403_0526OC
crossref_primary_10_1016_j_sleep_2014_05_022
crossref_primary_10_1016_j_jacc_2008_05_002
crossref_primary_10_1161_HYPERTENSIONAHA_113_00613
crossref_primary_10_1111_jch_14558
crossref_primary_10_1007_s11906_019_0974_3
crossref_primary_10_1586_14779072_2013_851002
crossref_primary_10_1016_j_jicc_2015_03_020
crossref_primary_10_1155_2013_356280
crossref_primary_10_1161_CIRCULATIONAHA_109_895235
crossref_primary_10_3389_fendo_2022_1016804
crossref_primary_10_1016_j_smrv_2019_07_001
crossref_primary_10_1016_j_jash_2010_03_005
crossref_primary_10_1161_CIRCRESAHA_118_310783
crossref_primary_10_2147_NSS_S340946
crossref_primary_10_3389_fphys_2019_00465
crossref_primary_10_1007_s11325_015_1311_y
crossref_primary_10_1007_s11906_014_0459_3
crossref_primary_10_1586_erc_09_120
crossref_primary_10_1038_s41371_019_0294_8
crossref_primary_10_17352_2455_2976_000001
crossref_primary_10_1536_ihj_14_034
crossref_primary_10_1093_eurheartj_ehs046
crossref_primary_10_1007_s11906_008_0045_7
crossref_primary_10_3810_pgm_2012_01_2519
crossref_primary_10_1007_s12020_024_03751_1
crossref_primary_10_1038_jhh_2015_15
crossref_primary_10_1016_j_jsmc_2017_01_003
crossref_primary_10_1038_jhh_2008_147
crossref_primary_10_1007_s11325_012_0755_6
crossref_primary_10_1016_j_pop_2008_06_001
crossref_primary_10_3810_pgm_2012_01_2520
crossref_primary_10_1161_HYPERTENSIONAHA_118_11780
crossref_primary_10_1097_HJH_0000000000000047
crossref_primary_10_18705_1607_419X_2012_18_3_184_190
crossref_primary_10_1097_HJH_0000000000001254
crossref_primary_10_1093_ajh_hpaa042
crossref_primary_10_1161_HYPERTENSIONAHA_116_07316
crossref_primary_10_1007_s40618_015_0338_z
crossref_primary_10_1016_j_semnephrol_2007_07_009
crossref_primary_10_1161_CIRCRESAHA_118_312156
crossref_primary_10_1586_ers_09_10
crossref_primary_10_1378_chest_14_0596
crossref_primary_10_1016_j_pcad_2018_07_005
crossref_primary_10_1097_HJH_0b013e328336ed85
crossref_primary_10_1007_s11906_013_0345_4
crossref_primary_10_2174_1573398X18666220915111251
crossref_primary_10_1152_japplphysiol_00689_2009
crossref_primary_10_1161_HYPERTENSIONAHA_120_16378
crossref_primary_10_1007_s11906_013_0411_y
crossref_primary_10_1111_j_1751_7176_2008_00012_x
crossref_primary_10_1016_j_jacc_2015_06_1315
crossref_primary_10_1002_hep_22143
crossref_primary_10_1097_HJH_0b013e328350e53b
crossref_primary_10_1007_s11596_016_1636_1
crossref_primary_10_3109_10641963_2015_1131290
crossref_primary_10_1016_j_ppotor_2014_02_004
crossref_primary_10_1016_j_metabol_2018_03_008
crossref_primary_10_1378_chest_15_0697
crossref_primary_10_1038_s41440_019_0314_7
crossref_primary_10_1371_journal_pone_0084362
crossref_primary_10_1586_14779072_2016_1132626
crossref_primary_10_1016_S1877_1203_13_70407_5
crossref_primary_10_1159_000450796
crossref_primary_10_1161_CIRCULATIONAHA_107_189420
crossref_primary_10_15829_1728_8800_2021_2845
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1378/chest.06-1442
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 17296647
Genre Journal Article
GroupedDBID ---
.1-
.55
.FO
.GJ
.XZ
08P
0R~
18M
1P~
29B
2WC
354
36B
3O-
457
53G
5GY
5RE
5RS
6J9
6PF
7RV
7X7
88E
8AO
8C1
8F7
8FI
8FJ
AAEDT
AAEDW
AAKAS
AAKUH
AALRI
AAWTL
AAXUO
AAYWO
ABDBF
ABDQB
ABJNI
ABLJU
ABMAC
ABOCM
ABUWG
ACBMB
ACGFO
ACGFS
ACGUR
ACUHS
ACVFH
ADBBV
ADCNI
ADGHP
ADVLN
ADZCM
AENEX
AEUPX
AEVXI
AFCTW
AFETI
AFFNX
AFJKZ
AFKRA
AFPUW
AFRHN
AFTJW
AGCQF
AGHFR
AHMBA
AI.
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
AZQEC
B0M
BCGUY
BENPR
BKEYQ
BKNYI
BPHCQ
BVXVI
C1A
C45
CCPQU
CGR
CS3
CUY
CVF
DU5
EAP
EAS
EBC
EBD
EBS
ECM
EFKBS
EHN
EIF
EJD
EMK
ENC
EPT
ESX
EX3
F5P
FDB
FYUFA
GD~
H13
HMCUK
HX~
HZ~
IH2
INR
J5H
K9-
L7B
LXL
LXN
M0R
M1P
M5~
MJL
MV1
N4W
N9A
NAPCQ
NEJ
NPM
O6.
O9-
OB3
OBH
ODZKP
OFXIZ
OGROG
OHH
OI-
OU.
OVD
OVIDX
P2P
PCD
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
Q~Q
RIG
ROL
SJN
SSZ
TCP
TEORI
TR2
TUS
TWZ
UKHRP
VH1
W8F
WH7
WOQ
WOW
X7M
XOL
YFH
YHG
YOC
YQJ
Z5R
ZGI
ZRQ
ZXP
ZY1
~8M
ID FETCH-LOGICAL-c455t-561311b45520b425b015ba0442c6a10db5a118380ffbd9b764ed2bfaee4c1fac2
ISSN 0012-3692
IngestDate Mon Jul 21 05:51:12 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c455t-561311b45520b425b015ba0442c6a10db5a118380ffbd9b764ed2bfaee4c1fac2
PMID 17296647
ParticipantIDs pubmed_primary_17296647
PublicationCentury 2000
PublicationDate 2007-02-01
PublicationDateYYYYMMDD 2007-02-01
PublicationDate_xml – month: 02
  year: 2007
  text: 2007-02-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Chest
PublicationTitleAlternate Chest
PublicationYear 2007
SSID ssj0001196
Score 2.3807619
Snippet Obstructive sleep apnea (OSA) and primary aldosteronism are common in subjects with resistant hypertension; it is unknown, however, if the two disorders are...
SourceID pubmed
SourceType Index Database
StartPage 453
SubjectTerms Adult
Aged
Aldosterone - blood
Case-Control Studies
Female
Humans
Hypertension - blood
Hypertension - complications
Male
Middle Aged
Polysomnography
Prospective Studies
Respiratory Function Tests
Severity of Illness Index
Sleep Apnea, Obstructive - blood
Sleep Apnea, Obstructive - complications
Title Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension
URI https://www.ncbi.nlm.nih.gov/pubmed/17296647
Volume 131
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF6cBkovoekrSdOyh96EUklePXxsQ0ooJIQSQ25hZx_ErS0ZWy40fyJ_uTOrlSwnbWl7EUILQtJ8Gn0zmvmGsXfEerVWNsyRK4RCZhDK3MShgiKxaTESRlC_89l5djoWn6_Sq8Hgrle1tKrhSN3-sq_kf6yKx9Cu1CX7D5btTooHcB_ti1u0MG7_ysYXSH1nMpBTTa0ai4oUQJZNewrySGSV-NkzC190UYHXiv1uguXUmHkg5yX1SZbBcgVfXVWHy8piAE6ksqyDGwxSF67E3RuvlTS4aX9KkVMlHeRwDKtSzhwTJTdBorDdT55zynPdym_SNwdN1rnVj5XRxvop2V8q-FEGXTb6uOrmZyMlVuTlNnIUeVvWvPa7JI2YjTb97jDuASzpeVHR6Ac_8O7DnDoW3CCxIxofJBphrp6l5zNnamRlGMY1Up5_Xr0ntt0ubbEtDDtojiolf_yHPY7duLfuZrxkK17V-41rIiFaf557wYojLZdP2Y6PNviHBjq7bGDKZ-zxma-neM6mDYJ4D0F8suQeQbyueIsgXlneQxB3COIOQXxS8hZBnBDEOwTxPoJesPGnk8vj09DP3wiVSNM6pNgyjgH3kwjQtwNSR5AR3qHKZBxpSCWGp8Mishb0CPJMGJ2AlcYIFVupkpfsUYkXvsf4EEgUSo8U9WILVRTC5gJMEiVaWJnn--xV85yu543IynX7BA9-u_KaPVlj7ZBtW3yrzRukiDW8dYb7CQPbal4
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+aldosterone+is+related+to+severity+of+obstructive+sleep+apnea+in+subjects+with+resistant+hypertension&rft.jtitle=Chest&rft.au=Pratt-Ubunama%2C+Monique+N&rft.au=Nishizaka%2C+Mari+K&rft.au=Boedefeld%2C+Robyn+L&rft.au=Cofield%2C+Stacey+S&rft.date=2007-02-01&rft.issn=0012-3692&rft.volume=131&rft.issue=2&rft.spage=453&rft_id=info:doi/10.1378%2Fchest.06-1442&rft_id=info%3Apmid%2F17296647&rft_id=info%3Apmid%2F17296647&rft.externalDocID=17296647
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-3692&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-3692&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-3692&client=summon